Adjuvant_radiation_therapy_in_patients_with_detectable_prostate_specific_antigen_following_radical_prostatectomy._Adjuvant_radiation_therapy_following_radical_prostatectomy_for_adenocarcinoma_of_the_prostate_was_given_to_25_patients._Of_these_patients_8_had_microscopic_lymph_node_metastasis,_8_had_seminal_vesicle_invasion_without_positive_lymph_nodes,_6_had_positive_surgical_margins_and_3_had_only_capsule_penetration._Their_only_evidence_of_residual_disease_was_detectable_serum_prostate_specific_antigen_(PSA)_by_the_Yang_assay._A_total_of_15_patients_(60%)_had_a_subsequent_decrease_in_PSA_to_less_than_0.3_ng./ml._and_an_additional_5_(20%)_had_a_decrease_in_PSA_by_more_than_50%._Currently_8_patients_have_no_detectable_PSA_after_a_median_followup_of_18_months_(17_to_38_months)_since_initiating_radiation_therapy._Only_1_of_12_patients_with_detectable_PSA_immediately_after_radical_prostatectomy_has_had_a_durable_response_to_adjuvant_radiation_therapy._In_contrast_7_of_13_patients_with_a_delayed_increase_in_PSA_had_a_durable_response._The_ability_of_adjuvant_radiation_therapy_to_eliminate_serum_PSA_in_patients_with_a_delayed_increase_in_PSA_after_radical_prostatectomy_is_encouraging._However,_longer_followup,_including_the_use_of_nonradiated_control_subjects,_is_needed_to_assess_the_ability_of_adjuvant_radiation_therapy_to_control_local_disease_and_prolong_patient_survival.